Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Become EABM
Become Reviewer

Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation

Volume:9   Issue: 8
Pp: 888-903
A. Carpi, A. Nicolini, A. Antonelli, P. Ferrari and G. Rossi
DOI: 10.2174/156800909790192392

Voltage-Dependent Potassium Channels Kv1.3 and Kv1.5 in Human Cancer

Volume:9   Issue: 8
Pp: 904-914
J. Bielanska, J. Hernandez-Losa, M. Perez-Verdaguer, T. Moline, R. Somoza, S. Ramon y Cajal, E. Condom, J. C. Ferreres and A. Felipe
DOI: 10.2174/156800909790192400

Gadd45 Proteins as Critical Signal Transducers Linking NF-κB to MAPK Cascades

Volume:9   Issue: 8
Pp: 915-930
Z. Yang, L. Song and C. Huang
DOI: 10.2174/156800909790192383

Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy

Volume:9   Issue: 8
Pp: 938-952
X. Liu, R. C. Newton, S. M. Friedman and P. A. Scherle
DOI: 10.2174/156800909790192374

Poly(ADP-ribose) Glycohydrolase Deficiency Sensitizes Mouse ES Cells to DNA Damaging Agents

Volume:9   Issue: 8
Pp: 953-962
H. Fujihara, H. Ogino, D. Maeda, H. Shirai, T. Nozaki, N. Kamada, K. Jishage, S. Tanuma, T. Takato, T. Ochiya, T. Sugimura and M. Masutani
DOI: 10.2174/156800909790192419

Epigenetic Therapy: Histone Acetylation, DNA Methylation and Anti-Cancer Drug Discovery

Volume:9   Issue: 8
Pp: 963-981
A. Ganesan, L. Nolan, S. J. Crabb and G. Packham
DOI: 10.2174/156800909790192428

Antibody-Drug Conjugate Targets

Volume:9   Issue: 8
Pp: 982-1004
B. A. Teicher
DOI: 10.2174/156800909790192365